Autoimmune cytopenias associated with autoantibodies to nuclear envelope polypeptides

American Journal of Hematology

Volumn 77, Issue 3, 2004, Pages 241-249

  Coppo, Paul ^a,d   Clauvel, Jean Pierre ^a   Bengoufa, Djaouida ^a   Fuentes, Vincent ^b   Gouilleux Gruart, Valérie ^b   Courvalin, Jean Claude ^c   Lassoued, Kaiss ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c INSTITUT JACQUES MONOD   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Antinuclear antibodies; Autoimmunity; Cytopenias; Lamins; Nuclear envelope

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; LAMIN A; LAMIN B; LAMIN C; PHOSPHOLIPID ANTIBODY; PROTEIN P52; STEROID;

ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL NUCLEUS MEMBRANE; CYTOPENIA; HEMOLYTIC ANEMIA; HUMAN; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS; NEUTROPENIA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COOMBS' TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; LIVER DISEASES; MALE; MIDDLE AGED; NEUTROPENIA; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; PANCYTOPENIA; PEPTIDES; PURPURA, THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULITIS;

EID: 7244227732     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20188     Document Type: Article

References (47)

1. Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210 kilodalton nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990;86:279-285.
2. Lassoued K, Guilly MN, André C, et al. Autoantibodies to a 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clin Exp Immunol 1988;74:283-288.
3. Lassoued K, Guilly MN, Danon F, et al. Antinuclear autoantibodies specific for lamins. Characterization and clinical significance. Ann Intern Med 1988;108:829-833.
4. Lassoued S, Okaman E, Fournie B, Danon F, Fournie A, Lassoued K. Autoantibodies to lamins in rheumatoid arthritis. Arthritis Rheum 1990;33:877-879.
5. Courvalin JC, Lassoued K, Worman HJ, Blobel G. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 1990;172:961-967.
6. Byrd DA, Sweet DJ, Panté N, et al. Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol 1994;127:1515-1526.
7. Furukawa K, Panté N, Aebi U, Gerace L. Cloning of a cDNA for lamina-associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. EMBO J 1995;14:1626-1636.
8. Konstantinov K, Foisner R, Byrd D, et al. Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunopathol 1995;74:89-99.
9. Martin L, Crimaudo C, Gerace L. cDNA cloning and characterization of lamina-associated polypeptide 1C (LAPIC), an integral protein of the inner nuclear membrane. J Biol Chem 1995; 270:8822-8828.
10. Lassoued K, Brenard R, Degos R, et al. Antinuclear antibodies directed to a 200 kD polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 1990;99:181-186.
11. Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, Johanet C. Specificity and sensibility of gp210 autoantibodies detected using an ELISA and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 1996;23: 1020-1024.
12. Courvalin JC, Worman HJ. Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:79-90.
13. Lassoued K, Andre C, Danon F, et al. Characterization of two human monoclonal IgM antibodies that recognize nuclear lamins. Eur J Immunol 1992;22:1547-1551.
14. Wesierka-Gadek J, Penner E, Hitchman E, Sauermann G. Antibodies to nuclear lamins in autoimmune liver disease. Clin Immunol Immunopathol 1988;49:107-115.
15. Konstantinov K, Halberg P, Wiik A, et al. Clinical manifestations in patients with autoantibodies specific for nuclear lamin proteins. Clin Immunol Immunopathol 1992;62:112-118.
16. Hill C, Roberts-Thomson P, Pollard A, Gillis D, Kirkham B. Clinical associations of antilamin autoantibodies. Aust NZ Med 1994;26:162-166.
17. Senecal JL, Rauch J, Grodzicky T, et al. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Arthritis Rheum 1999;42:1347-1353.
18. McKeon FD, Tuffanelli DL, Fukuyama K, Kirschner MW. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci USA 1983;80:4374-4378.
19. Dagenais A, Bibor-Hardy V, Senecal JL. A novel autoantibody causing a peripheral fluorescent antinuclear antibody pattern is specific for nuclear pore complexes. Arthritis Rheum 1988;31: 1322-1327.
20. Konstantinov K, von Mikecz A, Buchwald D. Jones J, Gerace L, Tan EM. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 1996;98:1888-1896.
21. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994;106:193-199.
22. Blobel G, Potter VR. Nuclei from rat liver: isolation method that combines purity with high yield. Science 1966;154:1662-1665.
23. Dwyer N, Blobel G. A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei. J Cell Biol 1976;70:581-591.
24. Guilly MN, Kolb JP, Gosti F, Godeau F, Courvalin JC. Lamins A and C are not expressed at early stages of human lymphocyte differentiation. Exp Cell Res 1990;189:145-147.
25. Preud'homme JL, Danon F, Rochard E, et al. Detection of anti-double-stranded DNA antibodies of IgG, IgA and IgM classes by ELISA. Comparison with the Farr test and indirect immunofluorescence. Presse Med 1988;17:1401-1404.
26. Harris EN. Special report. The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Anti-phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476-484.
27. Verheugt FWA, von dem Borne AEGKr, Decary F, Engelfriet CP. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol 1977;36:533-544.
28. Verheugt FWA, von dem Borne AEGKr, van Noord-Bokhorst JC, Engelfriet CP. Autoimmune granulocytopenia: the detection of granulocyte autoantibodies with immunofluorescence test. Br J Haematol 1978;39:339-350.
29. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-1726.
30. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
31. Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically proved cases and review of the literature. Am J Med 1980;69: 187-194.
32. Matsumoto T, Yoshimine T, Shimouchi K, et al. The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data. Hum Pathol 1992;23:1151-1158.
33. Matsumoto T, Kobayashi S, Shimizu H, et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000;20: 366-373.
34. Khamashta MA, Machin SJ. Hematological immune cytopenias and anti-phospholipid antibodies. In: Harris EN, Exner T. Hughes GRV, Asherson RA, editors. Phospholipid-binding antibodies. Boca Raton, FL: CRC Press Publishing; 1991. Vol 15, p 248-250.
35. Levine J, Branch W, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
36. Lassoued K, Danon F, Brouet JC. Human autoantibodies to lamin B receptor are also anti-idiotypic to certain anti-lamin B antibodies. Eur J Immunol 1991;21:1959-1962.
37. Papamarcaki T, Kouklis PD, Kreis TE, Georgatos SD. The "lamin B-fold". Anti-idiotypic antibodies reveal a structural complementarity between nuclear lamin B and cytoplasmic intermediate filament epitopes. J Biol Chem 1991;266:21247-21251.
38. Mariette X, Brouet JC, Danon F, Tsapis A, Lassoued K. Nucleotide sequence analysis of the VL and VH domains of five human IgM directed to lamin B. Arthritis Rheum 1993;36: 1315-1324.
39. Chou CH, Ali SA, Roubey R, Buyon J, Reeves WH. Onset and regulation of anti-lamin B autoantibody production is independent of the level of polyclonal activation. Autoimmunity 1991;8: 297-305.
40. Reeves WH, Ali SA. Preferential use of lambda L chain in lamin B autoantibodies. J Immunol 1989;143:3614-3618.
41. Burke B. Lamins and apoptosis: a two-way street? J Cell Biol 2001;153:F5-F7.
42. Shimizu T, Cao CX, Shao RG, Pommier Y. Lamin B phosphorylation by protein kinase C alpha and proteolysis during apoptosis in human leukemia HL60 cells. J Biol Chem 1998;273: 8669-8674.
43. Scott RS, McMahon EJ, Pop SM, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001;411: 207-211.
44. Ajiro K. Histone H2B phosphorylation in mammalian apoptotic cells. An association with DNA fragmentation. J Biol Chem 2000; 275:439-443.
45. Utz PJ, Hottelet M, van Venrooij WJ, Anderson P. Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death. J Exp Med 1998;187:547-560.
46. Guilly MN, Danon F, Brouet JC, Bornens M, Courvalin JC. Autoantibodies to nuclear lamin B in a patient with thrombopenia. Eur J Cell Biol 1987;43:266-272.
47. Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. J Autoimm 1996;9: 295-300.